TRAX Insider Dennis Fenton Sells 6,030 Shares
Dennis Fenton sold 6,030 shares of TRAX on June 15, marking notable insider activity.
Reviewed by automated data checks against the source filing. How we make and check alerts
Dennis Fenton sold 6,030 shares of First Tracks Biotherapeutics, Inc. ($TRAX) on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $TRAX is up 2.5% after 1 week, up 102.1% after 1 month and up 92.7% to date (from the $17.88 close on Jun 15, 2026).
TRAX
First Tracks Biotherapeutics, Inc.
Key Points
- Dennis Fenton sold 6,030 shares of TRAX on June 15, 2026, while the stock traded at $18.17.
- TRAX saw insider buying activity on the same day from John Schmid, Magda Marquet, Anthony Ware, and Rita Jain.
- Analysts from Wells Fargo, Piper Sandler, and others have initiated buy ratings with targets up to $54.
Get $TRAX trade alerts by text
We text you when insiders, Congress or big funds trade $TRAX. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated First Tracks Biotherapeutics, Inc. alert may contain errors. Disclosures
Dennis Fenton, an insider at TRAX, sold 6,030 shares on June 15, 2026. The stock was trading at $18.17 at the time of the transaction. This move was part of a series of insider activities on the same day.
Insider Buying and Selling at First Tracks Biotherapeutics, Inc.
On June 15, 2026, several insiders were active in TRAX's stock. John Schmid, Magda Marquet, Anthony Ware, and Rita Jain each purchased 6,030 shares, while Jain acquired 7,330 shares. Meanwhile, John Orwin and Dennis Fenton sold 6,030 shares each. None of these transactions were planned under a Rule 10b5-1 plan.
Analysts Set New Price Targets
Analysts are optimistic about TRAX's prospects. On June 8, 2026, Wells Fargo initiated coverage with a buy rating and a $30 price target. Piper Sandler followed on May 4 with a buy rating and a $54 target. Other firms like HC Wainwright & Co., Leerink Partners, and JP Morgan have also initiated buy ratings, with targets ranging from $30 to $46.
Bottom Line
Insider trading activity at TRAX on June 15, 2026, shows both buying and selling, reflecting diverse perspectives among insiders. Analysts are generally bullish, with several firms initiating buy ratings and setting price targets well above the current trading price. This insider and analyst activity provides valuable insights, though it is backward-looking and may not reflect current positions or opinions.
Related Filing Alerts
Source: Dennis Fenton's Form 4 filing on $TRAX (Jun 15, 2026). Find the original filing: TRAX Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts